Business & Finance
Genmab discloses details of the issue of shares to GlaxoSmithKline
Published in Drug Law Weekly, January 16th, 2007
In connection with Stock Exchange Release No. 60 concerning the worldwide agreement to co-develop and commercialize HuMax-CD20 (ofatumumab) entered into between Genmab A/S (CSE: GEN) and GlaxoSmithKline (GSK) and the subscription to Genmab shares by GSK according to the securities purchase agreement entered into, Genmab hereby discloses the following additional information regarding the issue of shares to GSK:
The issue of new shares to GSK consists of a private placement by Genmab to Glaxo Group Limited, a private limited company registered under the laws of England, of 4,471,202 new ordinary bearer shares of nominal value DKK 1 (one) each.
The new...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2007-01-16)
More Articles from Drug Law Weekly
- Awards
Neuropharma receives Frost & Sullivan International Excellence in Technology award - Business Update
Advancis closes private placement of common equity, files application for Pulsys - Business Update
Analytical Spectral Devices launches portable drug anti-counterfeiting technology - Business Update
Anchen announces approval of generic version of Wellbutrin XL - Diabetes Management
Eli Lilly and Company responds to New York Times article of 12/17/06 - Finance
AEterna shareholders approve reduction in stated capital, distribution of shares of Atrium - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
